nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Cladribine—PNP—osteoporosis	0.0104	0.763	CrCbGaD
Adenosine—Glucosamine—TNF—osteoporosis	0.00323	0.237	CrCbGaD
Adenosine—Hyperhidrosis—Raloxifene—osteoporosis	0.00134	0.00226	CcSEcCtD
Adenosine—Hyperhidrosis—Ibandronate—osteoporosis	0.00132	0.00224	CcSEcCtD
Adenosine—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.00132	0.00224	CcSEcCtD
Adenosine—Nausea—Ergocalciferol—osteoporosis	0.00132	0.00223	CcSEcCtD
Adenosine—Urticaria—Etidronic acid—osteoporosis	0.00131	0.00222	CcSEcCtD
Adenosine—Bronchospasm—Estradiol—osteoporosis	0.00131	0.00221	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.0013	0.0022	CcSEcCtD
Adenosine—Angioedema—Ethinyl Estradiol—osteoporosis	0.0013	0.00219	CcSEcCtD
Adenosine—Tension—Pamidronate—osteoporosis	0.00129	0.00218	CcSEcCtD
Adenosine—Dysgeusia—Pamidronate—osteoporosis	0.00129	0.00218	CcSEcCtD
Adenosine—Paraesthesia—Estropipate—osteoporosis	0.00128	0.00217	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00128	0.00217	CcSEcCtD
Adenosine—Cardiac disorder—Zoledronate—osteoporosis	0.00128	0.00217	CcSEcCtD
Adenosine—Flushing—Zoledronate—osteoporosis	0.00128	0.00217	CcSEcCtD
Adenosine—Nervousness—Pamidronate—osteoporosis	0.00128	0.00216	CcSEcCtD
Adenosine—Abdominal discomfort—Estradiol—osteoporosis	0.00127	0.00216	CcSEcCtD
Adenosine—Back pain—Pamidronate—osteoporosis	0.00127	0.00215	CcSEcCtD
Adenosine—Somnolence—Estropipate—osteoporosis	0.00127	0.00215	CcSEcCtD
Adenosine—Angioedema—Risedronate—osteoporosis	0.00126	0.00214	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00126	0.00213	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00125	0.00211	CcSEcCtD
Adenosine—Mediastinal disorder—Zoledronate—osteoporosis	0.00124	0.0021	CcSEcCtD
Adenosine—Syncope—Risedronate—osteoporosis	0.00124	0.0021	CcSEcCtD
Adenosine—Cough—Ethinyl Estradiol—osteoporosis	0.00124	0.0021	CcSEcCtD
Adenosine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00123	0.00209	CcSEcCtD
Adenosine—Arrhythmia—Zoledronate—osteoporosis	0.00123	0.00209	CcSEcCtD
Adenosine—Paraesthesia—Ibandronate—osteoporosis	0.00123	0.00208	CcSEcCtD
Adenosine—Pollakiuria—Estradiol—osteoporosis	0.00123	0.00208	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00122	0.00207	CcSEcCtD
Adenosine—Pain—Estropipate—osteoporosis	0.00122	0.00207	CcSEcCtD
Adenosine—Hypersensitivity—Etidronic acid—osteoporosis	0.00122	0.00206	CcSEcCtD
Adenosine—Loss of consciousness—Risedronate—osteoporosis	0.00122	0.00206	CcSEcCtD
Adenosine—Agitation—Pamidronate—osteoporosis	0.00121	0.00205	CcSEcCtD
Adenosine—Cough—Risedronate—osteoporosis	0.00121	0.00204	CcSEcCtD
Adenosine—Anxiety—Ethinyl Estradiol—osteoporosis	0.0012	0.00204	CcSEcCtD
Adenosine—Pain—Alendronate—osteoporosis	0.0012	0.00204	CcSEcCtD
Adenosine—Angioedema—Pamidronate—osteoporosis	0.0012	0.00203	CcSEcCtD
Adenosine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.0012	0.00203	CcSEcCtD
Adenosine—Hypertension—Risedronate—osteoporosis	0.00119	0.00202	CcSEcCtD
Adenosine—Discomfort—Ethinyl Estradiol—osteoporosis	0.00119	0.00202	CcSEcCtD
Adenosine—Somnolence—Calcitriol—osteoporosis	0.00119	0.00202	CcSEcCtD
Adenosine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00119	0.00201	CcSEcCtD
Adenosine—Pain—Raloxifene—osteoporosis	0.00118	0.002	CcSEcCtD
Adenosine—Syncope—Pamidronate—osteoporosis	0.00118	0.002	CcSEcCtD
Adenosine—Chest pain—Risedronate—osteoporosis	0.00118	0.00199	CcSEcCtD
Adenosine—Dysgeusia—Zoledronate—osteoporosis	0.00118	0.00199	CcSEcCtD
Adenosine—Anxiety—Risedronate—osteoporosis	0.00117	0.00199	CcSEcCtD
Adenosine—Pain—Ibandronate—osteoporosis	0.00117	0.00198	CcSEcCtD
Adenosine—Acute coronary syndrome—Estradiol—osteoporosis	0.00117	0.00198	CcSEcCtD
Adenosine—Back pain—Zoledronate—osteoporosis	0.00116	0.00197	CcSEcCtD
Adenosine—Myocardial infarction—Estradiol—osteoporosis	0.00116	0.00197	CcSEcCtD
Adenosine—Loss of consciousness—Pamidronate—osteoporosis	0.00116	0.00196	CcSEcCtD
Adenosine—Dry mouth—Risedronate—osteoporosis	0.00115	0.00195	CcSEcCtD
Adenosine—Cough—Pamidronate—osteoporosis	0.00115	0.00194	CcSEcCtD
Adenosine—Pain—Calcitriol—osteoporosis	0.00115	0.00194	CcSEcCtD
Adenosine—Convulsion—Pamidronate—osteoporosis	0.00114	0.00193	CcSEcCtD
Adenosine—Hypertension—Pamidronate—osteoporosis	0.00114	0.00192	CcSEcCtD
Adenosine—Tension—Conjugated Estrogens—osteoporosis	0.00114	0.00192	CcSEcCtD
Adenosine—Urticaria—Estropipate—osteoporosis	0.00113	0.00192	CcSEcCtD
Adenosine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00113	0.00192	CcSEcCtD
Adenosine—Vision blurred—Zoledronate—osteoporosis	0.00113	0.00192	CcSEcCtD
Adenosine—Tremor—Zoledronate—osteoporosis	0.00113	0.0019	CcSEcCtD
Adenosine—Nervousness—Conjugated Estrogens—osteoporosis	0.00112	0.0019	CcSEcCtD
Adenosine—Back pain—Conjugated Estrogens—osteoporosis	0.00112	0.00189	CcSEcCtD
Adenosine—Urticaria—Alendronate—osteoporosis	0.00112	0.00189	CcSEcCtD
Adenosine—Anxiety—Pamidronate—osteoporosis	0.00112	0.00189	CcSEcCtD
Adenosine—Shock—Risedronate—osteoporosis	0.00111	0.00188	CcSEcCtD
Adenosine—Discomfort—Pamidronate—osteoporosis	0.00111	0.00187	CcSEcCtD
Adenosine—Agitation—Zoledronate—osteoporosis	0.0011	0.00187	CcSEcCtD
Adenosine—Angioedema—Zoledronate—osteoporosis	0.0011	0.00186	CcSEcCtD
Adenosine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00109	0.00185	CcSEcCtD
Adenosine—Urticaria—Ibandronate—osteoporosis	0.00109	0.00184	CcSEcCtD
Adenosine—Syncope—Zoledronate—osteoporosis	0.00108	0.00182	CcSEcCtD
Adenosine—Anaphylactic shock—Pamidronate—osteoporosis	0.00107	0.00182	CcSEcCtD
Adenosine—Urticaria—Calcitriol—osteoporosis	0.00107	0.0018	CcSEcCtD
Adenosine—Palpitations—Zoledronate—osteoporosis	0.00106	0.0018	CcSEcCtD
Adenosine—Hypoaesthesia—Estradiol—osteoporosis	0.00106	0.00179	CcSEcCtD
Adenosine—Angioedema—Conjugated Estrogens—osteoporosis	0.00106	0.00179	CcSEcCtD
Adenosine—Shock—Pamidronate—osteoporosis	0.00106	0.00179	CcSEcCtD
Adenosine—Loss of consciousness—Zoledronate—osteoporosis	0.00106	0.00179	CcSEcCtD
Adenosine—Hypersensitivity—Estropipate—osteoporosis	0.00105	0.00178	CcSEcCtD
Adenosine—Vomiting—Etidronic acid—osteoporosis	0.00105	0.00178	CcSEcCtD
Adenosine—Cough—Zoledronate—osteoporosis	0.00105	0.00177	CcSEcCtD
Adenosine—Tachycardia—Pamidronate—osteoporosis	0.00105	0.00177	CcSEcCtD
Adenosine—Rash—Etidronic acid—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Convulsion—Zoledronate—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Dermatitis—Etidronic acid—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Hyperhidrosis—Pamidronate—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Syncope—Conjugated Estrogens—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Hypertension—Zoledronate—osteoporosis	0.00104	0.00176	CcSEcCtD
Adenosine—Hypersensitivity—Alendronate—osteoporosis	0.00104	0.00175	CcSEcCtD
Adenosine—Headache—Etidronic acid—osteoporosis	0.00103	0.00175	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00103	0.00174	CcSEcCtD
Adenosine—Asthenia—Estropipate—osteoporosis	0.00103	0.00173	CcSEcCtD
Adenosine—Chest pain—Zoledronate—osteoporosis	0.00102	0.00173	CcSEcCtD
Adenosine—Palpitations—Conjugated Estrogens—osteoporosis	0.00102	0.00173	CcSEcCtD
Adenosine—Anxiety—Zoledronate—osteoporosis	0.00102	0.00172	CcSEcCtD
Adenosine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00102	0.00172	CcSEcCtD
Adenosine—Paraesthesia—Risedronate—osteoporosis	0.00101	0.00172	CcSEcCtD
Adenosine—Discomfort—Zoledronate—osteoporosis	0.00101	0.00171	CcSEcCtD
Adenosine—Asthenia—Alendronate—osteoporosis	0.00101	0.00171	CcSEcCtD
Adenosine—Hypersensitivity—Ibandronate—osteoporosis	0.00101	0.00171	CcSEcCtD
Adenosine—Cough—Conjugated Estrogens—osteoporosis	0.00101	0.00171	CcSEcCtD
Adenosine—Dyspnoea—Risedronate—osteoporosis	0.00101	0.0017	CcSEcCtD
Adenosine—Hypotension—Pamidronate—osteoporosis	0.001	0.0017	CcSEcCtD
Adenosine—Convulsion—Conjugated Estrogens—osteoporosis	0.001	0.0017	CcSEcCtD
Adenosine—Dry mouth—Zoledronate—osteoporosis	0.001	0.00169	CcSEcCtD
Adenosine—Tinnitus—Estradiol—osteoporosis	0.000991	0.00168	CcSEcCtD
Adenosine—Hypersensitivity—Calcitriol—osteoporosis	0.000988	0.00167	CcSEcCtD
Adenosine—Cardiac disorder—Estradiol—osteoporosis	0.000987	0.00167	CcSEcCtD
Adenosine—Flushing—Estradiol—osteoporosis	0.000987	0.00167	CcSEcCtD
Adenosine—Chest pain—Conjugated Estrogens—osteoporosis	0.000985	0.00167	CcSEcCtD
Adenosine—Asthenia—Ibandronate—osteoporosis	0.000983	0.00166	CcSEcCtD
Adenosine—Anxiety—Conjugated Estrogens—osteoporosis	0.000981	0.00166	CcSEcCtD
Adenosine—Nausea—Etidronic acid—osteoporosis	0.000981	0.00166	CcSEcCtD
Adenosine—Anaphylactic shock—Zoledronate—osteoporosis	0.00098	0.00166	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000978	0.00166	CcSEcCtD
Adenosine—Pain—Risedronate—osteoporosis	0.000965	0.00163	CcSEcCtD
Adenosine—Shock—Zoledronate—osteoporosis	0.000965	0.00163	CcSEcCtD
Adenosine—Paraesthesia—Pamidronate—osteoporosis	0.000964	0.00163	CcSEcCtD
Adenosine—Asthenia—Calcitriol—osteoporosis	0.000962	0.00163	CcSEcCtD
Adenosine—Mediastinal disorder—Estradiol—osteoporosis	0.000958	0.00162	CcSEcCtD
Adenosine—Dyspnoea—Pamidronate—osteoporosis	0.000957	0.00162	CcSEcCtD
Adenosine—Tachycardia—Zoledronate—osteoporosis	0.000957	0.00162	CcSEcCtD
Adenosine—Somnolence—Pamidronate—osteoporosis	0.000954	0.00161	CcSEcCtD
Adenosine—Hyperhidrosis—Zoledronate—osteoporosis	0.000948	0.0016	CcSEcCtD
Adenosine—Dizziness—Estropipate—osteoporosis	0.000945	0.0016	CcSEcCtD
Adenosine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000944	0.0016	CcSEcCtD
Adenosine—Dizziness—Alendronate—osteoporosis	0.000931	0.00157	CcSEcCtD
Adenosine—Shock—Conjugated Estrogens—osteoporosis	0.000929	0.00157	CcSEcCtD
Adenosine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000921	0.00156	CcSEcCtD
Adenosine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00092	0.00156	CcSEcCtD
Adenosine—Pain—Pamidronate—osteoporosis	0.000918	0.00155	CcSEcCtD
Adenosine—Hypotension—Zoledronate—osteoporosis	0.000916	0.00155	CcSEcCtD
Adenosine—Dizziness—Raloxifene—osteoporosis	0.000915	0.00155	CcSEcCtD
Adenosine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000913	0.00154	CcSEcCtD
Adenosine—Tension—Estradiol—osteoporosis	0.000908	0.00154	CcSEcCtD
Adenosine—Vomiting—Estropipate—osteoporosis	0.000908	0.00154	CcSEcCtD
Adenosine—Dysgeusia—Estradiol—osteoporosis	0.000907	0.00153	CcSEcCtD
Adenosine—Dizziness—Ibandronate—osteoporosis	0.000906	0.00153	CcSEcCtD
Adenosine—Rash—Estropipate—osteoporosis	0.000901	0.00152	CcSEcCtD
Adenosine—Dermatitis—Estropipate—osteoporosis	0.0009	0.00152	CcSEcCtD
Adenosine—Nervousness—Estradiol—osteoporosis	0.000899	0.00152	CcSEcCtD
Adenosine—Urticaria—Risedronate—osteoporosis	0.000897	0.00152	CcSEcCtD
Adenosine—Back pain—Estradiol—osteoporosis	0.000895	0.00152	CcSEcCtD
Adenosine—Headache—Estropipate—osteoporosis	0.000895	0.00151	CcSEcCtD
Adenosine—Vomiting—Alendronate—osteoporosis	0.000895	0.00151	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000893	0.00151	CcSEcCtD
Adenosine—Rash—Alendronate—osteoporosis	0.000887	0.0015	CcSEcCtD
Adenosine—Dermatitis—Alendronate—osteoporosis	0.000886	0.0015	CcSEcCtD
Adenosine—Hypotension—Conjugated Estrogens—osteoporosis	0.000882	0.00149	CcSEcCtD
Adenosine—Headache—Alendronate—osteoporosis	0.000882	0.00149	CcSEcCtD
Adenosine—Paraesthesia—Zoledronate—osteoporosis	0.00088	0.00149	CcSEcCtD
Adenosine—Vomiting—Raloxifene—osteoporosis	0.00088	0.00149	CcSEcCtD
Adenosine—Dyspnoea—Zoledronate—osteoporosis	0.000874	0.00148	CcSEcCtD
Adenosine—Rash—Raloxifene—osteoporosis	0.000873	0.00148	CcSEcCtD
Adenosine—Dermatitis—Raloxifene—osteoporosis	0.000872	0.00148	CcSEcCtD
Adenosine—Somnolence—Zoledronate—osteoporosis	0.000872	0.00148	CcSEcCtD
Adenosine—Vomiting—Ibandronate—osteoporosis	0.000871	0.00147	CcSEcCtD
Adenosine—Tremor—Estradiol—osteoporosis	0.000867	0.00147	CcSEcCtD
Adenosine—Headache—Raloxifene—osteoporosis	0.000867	0.00147	CcSEcCtD
Adenosine—Rash—Ibandronate—osteoporosis	0.000864	0.00146	CcSEcCtD
Adenosine—Dermatitis—Ibandronate—osteoporosis	0.000863	0.00146	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00086	0.00146	CcSEcCtD
Adenosine—Headache—Ibandronate—osteoporosis	0.000858	0.00145	CcSEcCtD
Adenosine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000853	0.00144	CcSEcCtD
Adenosine—Vomiting—Calcitriol—osteoporosis	0.000853	0.00144	CcSEcCtD
Adenosine—Agitation—Estradiol—osteoporosis	0.000851	0.00144	CcSEcCtD
Adenosine—Nausea—Estropipate—osteoporosis	0.000849	0.00144	CcSEcCtD
Adenosine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000848	0.00143	CcSEcCtD
Adenosine—Angioedema—Estradiol—osteoporosis	0.000846	0.00143	CcSEcCtD
Adenosine—Rash—Calcitriol—osteoporosis	0.000846	0.00143	CcSEcCtD
Adenosine—Dermatitis—Calcitriol—osteoporosis	0.000845	0.00143	CcSEcCtD
Adenosine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000842	0.00142	CcSEcCtD
Adenosine—Headache—Calcitriol—osteoporosis	0.00084	0.00142	CcSEcCtD
Adenosine—Somnolence—Conjugated Estrogens—osteoporosis	0.000839	0.00142	CcSEcCtD
Adenosine—Pain—Zoledronate—osteoporosis	0.000838	0.00142	CcSEcCtD
Adenosine—Nausea—Alendronate—osteoporosis	0.000836	0.00141	CcSEcCtD
Adenosine—Hypersensitivity—Risedronate—osteoporosis	0.000832	0.00141	CcSEcCtD
Adenosine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000831	0.00141	CcSEcCtD
Adenosine—Syncope—Estradiol—osteoporosis	0.00083	0.00141	CcSEcCtD
Adenosine—Nausea—Raloxifene—osteoporosis	0.000822	0.00139	CcSEcCtD
Adenosine—Palpitations—Estradiol—osteoporosis	0.000818	0.00138	CcSEcCtD
Adenosine—Nausea—Ibandronate—osteoporosis	0.000814	0.00138	CcSEcCtD
Adenosine—Loss of consciousness—Estradiol—osteoporosis	0.000814	0.00138	CcSEcCtD
Adenosine—Asthenia—Risedronate—osteoporosis	0.00081	0.00137	CcSEcCtD
Adenosine—Cough—Estradiol—osteoporosis	0.000808	0.00137	CcSEcCtD
Adenosine—Pain—Conjugated Estrogens—osteoporosis	0.000807	0.00137	CcSEcCtD
Adenosine—Hypertension—Estradiol—osteoporosis	0.000799	0.00135	CcSEcCtD
Adenosine—Nausea—Calcitriol—osteoporosis	0.000797	0.00135	CcSEcCtD
Adenosine—Hypersensitivity—Pamidronate—osteoporosis	0.000791	0.00134	CcSEcCtD
Adenosine—Chest pain—Estradiol—osteoporosis	0.000788	0.00133	CcSEcCtD
Adenosine—ADK—Metabolism—CA2—osteoporosis	0.000788	0.00199	CbGpPWpGaD
Adenosine—Anxiety—Estradiol—osteoporosis	0.000785	0.00133	CcSEcCtD
Adenosine—ADORA2A—G alpha (s) signalling events—ADCY5—osteoporosis	0.000781	0.00198	CbGpPWpGaD
Adenosine—Urticaria—Zoledronate—osteoporosis	0.000779	0.00132	CcSEcCtD
Adenosine—Discomfort—Estradiol—osteoporosis	0.000779	0.00132	CcSEcCtD
Adenosine—Dry mouth—Estradiol—osteoporosis	0.000771	0.0013	CcSEcCtD
Adenosine—Asthenia—Pamidronate—osteoporosis	0.00077	0.0013	CcSEcCtD
Adenosine—ADK—Metabolism—MGLL—osteoporosis	0.000768	0.00194	CbGpPWpGaD
Adenosine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000766	0.0013	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—WNT1—osteoporosis	0.000763	0.00193	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PTH1R—osteoporosis	0.000762	0.00193	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CALCR—osteoporosis	0.000762	0.00193	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—RAP1A—osteoporosis	0.000758	0.00192	CbGpPWpGaD
Adenosine—Anaphylactic shock—Estradiol—osteoporosis	0.000756	0.00128	CcSEcCtD
Adenosine—Urticaria—Conjugated Estrogens—osteoporosis	0.00075	0.00127	CcSEcCtD
Adenosine—Dizziness—Risedronate—osteoporosis	0.000747	0.00126	CcSEcCtD
Adenosine—Shock—Estradiol—osteoporosis	0.000743	0.00126	CcSEcCtD
Adenosine—Tachycardia—Estradiol—osteoporosis	0.000737	0.00125	CcSEcCtD
Adenosine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000736	0.00125	CcSEcCtD
Adenosine—Hyperhidrosis—Estradiol—osteoporosis	0.00073	0.00124	CcSEcCtD
Adenosine—Rash—Ethinyl Estradiol—osteoporosis	0.00073	0.00124	CcSEcCtD
Adenosine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000729	0.00123	CcSEcCtD
Adenosine—ADA—Metabolism—PKM—osteoporosis	0.000727	0.00184	CbGpPWpGaD
Adenosine—ADA—Metabolism—FDPS—osteoporosis	0.000727	0.00184	CbGpPWpGaD
Adenosine—Headache—Ethinyl Estradiol—osteoporosis	0.000725	0.00123	CcSEcCtD
Adenosine—Hypersensitivity—Zoledronate—osteoporosis	0.000722	0.00122	CcSEcCtD
Adenosine—Vomiting—Risedronate—osteoporosis	0.000718	0.00122	CcSEcCtD
Adenosine—Rash—Risedronate—osteoporosis	0.000712	0.0012	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—MGLL—osteoporosis	0.000712	0.0018	CbGpPWpGaD
Adenosine—Dermatitis—Risedronate—osteoporosis	0.000711	0.0012	CcSEcCtD
Adenosine—Dizziness—Pamidronate—osteoporosis	0.00071	0.0012	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—PTH—osteoporosis	0.000708	0.00179	CbGpPWpGaD
Adenosine—Headache—Risedronate—osteoporosis	0.000707	0.0012	CcSEcCtD
Adenosine—Asthenia—Zoledronate—osteoporosis	0.000703	0.00119	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0007	0.00177	CbGpPWpGaD
Adenosine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000695	0.00118	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—CALCR—osteoporosis	0.000692	0.00175	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTH1R—osteoporosis	0.000692	0.00175	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—MYC—osteoporosis	0.000691	0.00175	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—PTHLH—osteoporosis	0.00069	0.00174	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CNR2—osteoporosis	0.00069	0.00174	CbGpPWpGaD
Adenosine—ADA—Metabolism—GPD2—osteoporosis	0.000689	0.00174	CbGpPWpGaD
Adenosine—ADA—Metabolism—PGLS—osteoporosis	0.000689	0.00174	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000688	0.00117	CcSEcCtD
Adenosine—Nausea—Ethinyl Estradiol—osteoporosis	0.000688	0.00116	CcSEcCtD
Adenosine—Vomiting—Pamidronate—osteoporosis	0.000682	0.00116	CcSEcCtD
Adenosine—Paraesthesia—Estradiol—osteoporosis	0.000678	0.00115	CcSEcCtD
Adenosine—Asthenia—Conjugated Estrogens—osteoporosis	0.000677	0.00115	CcSEcCtD
Adenosine—Rash—Pamidronate—osteoporosis	0.000677	0.00115	CcSEcCtD
Adenosine—Dermatitis—Pamidronate—osteoporosis	0.000676	0.00114	CcSEcCtD
Adenosine—Dyspnoea—Estradiol—osteoporosis	0.000674	0.00114	CcSEcCtD
Adenosine—Headache—Pamidronate—osteoporosis	0.000672	0.00114	CcSEcCtD
Adenosine—Somnolence—Estradiol—osteoporosis	0.000672	0.00114	CcSEcCtD
Adenosine—Nausea—Risedronate—osteoporosis	0.000671	0.00114	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KL—osteoporosis	0.000665	0.00168	CbGpPWpGaD
Adenosine—ADK—Metabolism—IDH2—osteoporosis	0.000653	0.00165	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—WNT1—osteoporosis	0.000649	0.00164	CbGpPWpGaD
Adenosine—Dizziness—Zoledronate—osteoporosis	0.000648	0.0011	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—MGLL—osteoporosis	0.000646	0.00163	CbGpPWpGaD
Adenosine—Pain—Estradiol—osteoporosis	0.000646	0.00109	CcSEcCtD
Adenosine—Nausea—Pamidronate—osteoporosis	0.000638	0.00108	CcSEcCtD
Adenosine—ADA—Metabolism—ATIC—osteoporosis	0.00063	0.00159	CbGpPWpGaD
Adenosine—ADA—Metabolism—PNP—osteoporosis	0.00063	0.00159	CbGpPWpGaD
Adenosine—Dizziness—Conjugated Estrogens—osteoporosis	0.000624	0.00106	CcSEcCtD
Adenosine—Vomiting—Zoledronate—osteoporosis	0.000623	0.00106	CcSEcCtD
Adenosine—Rash—Zoledronate—osteoporosis	0.000618	0.00105	CcSEcCtD
Adenosine—Dermatitis—Zoledronate—osteoporosis	0.000618	0.00105	CcSEcCtD
Adenosine—Headache—Zoledronate—osteoporosis	0.000614	0.00104	CcSEcCtD
Adenosine—ADK—Metabolism—CYP27A1—osteoporosis	0.000614	0.00155	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CALCA—osteoporosis	0.000608	0.00154	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—ADCY5—osteoporosis	0.000607	0.00153	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—MGLL—osteoporosis	0.000605	0.00153	CbGpPWpGaD
Adenosine—Vomiting—Conjugated Estrogens—osteoporosis	0.0006	0.00102	CcSEcCtD
Adenosine—Urticaria—Estradiol—osteoporosis	0.0006	0.00102	CcSEcCtD
Adenosine—ADK—Metabolism—ACP5—osteoporosis	0.000597	0.00151	CbGpPWpGaD
Adenosine—Rash—Conjugated Estrogens—osteoporosis	0.000595	0.00101	CcSEcCtD
Adenosine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000595	0.00101	CcSEcCtD
Adenosine—Headache—Conjugated Estrogens—osteoporosis	0.000591	0.001	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—LEP—osteoporosis	0.000589	0.00149	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CALCR—osteoporosis	0.000588	0.00149	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PTH1R—osteoporosis	0.000588	0.00149	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—PTHLH—osteoporosis	0.000587	0.00148	CbGpPWpGaD
Adenosine—Nausea—Zoledronate—osteoporosis	0.000582	0.000986	CcSEcCtD
Adenosine—ADORA2A—G alpha (s) signalling events—POMC—osteoporosis	0.000575	0.00145	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—ACE—osteoporosis	0.000574	0.00145	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000563	0.00142	CbGpPWpGaD
Adenosine—Nausea—Conjugated Estrogens—osteoporosis	0.000561	0.000949	CcSEcCtD
Adenosine—Hypersensitivity—Estradiol—osteoporosis	0.000557	0.000942	CcSEcCtD
Adenosine—ADK—Metabolism—TPI1—osteoporosis	0.000555	0.0014	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MGLL—osteoporosis	0.00055	0.00139	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—PTH—osteoporosis	0.000547	0.00138	CbGpPWpGaD
Adenosine—Asthenia—Estradiol—osteoporosis	0.000542	0.000917	CcSEcCtD
Adenosine—ADA—Metabolism—CA2—osteoporosis	0.000536	0.00135	CbGpPWpGaD
Adenosine—ADA—Metabolism—OXCT1—osteoporosis	0.000536	0.00135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CALCR—osteoporosis	0.000534	0.00135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTH1R—osteoporosis	0.000534	0.00135	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CNR2—osteoporosis	0.000533	0.00135	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SOST—osteoporosis	0.000531	0.00134	CbGpPWpGaD
Adenosine—ADK—Metabolism—P4HB—osteoporosis	0.000522	0.00132	CbGpPWpGaD
Adenosine—ADA—Metabolism—MGLL—osteoporosis	0.000522	0.00132	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ADCY5—osteoporosis	0.000521	0.00132	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CALCA—osteoporosis	0.000517	0.00131	CbGpPWpGaD
Adenosine—ADK—Metabolism—GAPDH—osteoporosis	0.000512	0.0013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KL—osteoporosis	0.000511	0.00129	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—WNT1—osteoporosis	0.000501	0.00127	CbGpPWpGaD
Adenosine—Dizziness—Estradiol—osteoporosis	0.0005	0.000846	CcSEcCtD
Adenosine—ADK—Metabolism—RAP1A—osteoporosis	0.000499	0.00126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CALCR—osteoporosis	0.000481	0.00122	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTH1R—osteoporosis	0.000481	0.00122	CbGpPWpGaD
Adenosine—Vomiting—Estradiol—osteoporosis	0.00048	0.000813	CcSEcCtD
Adenosine—Rash—Estradiol—osteoporosis	0.000476	0.000806	CcSEcCtD
Adenosine—Dermatitis—Estradiol—osteoporosis	0.000476	0.000806	CcSEcCtD
Adenosine—Headache—Estradiol—osteoporosis	0.000473	0.000801	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—PTH—osteoporosis	0.000471	0.00119	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—MGLL—osteoporosis	0.000467	0.00118	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CNR2—osteoporosis	0.000459	0.00116	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS2—osteoporosis	0.000456	0.00115	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—LEP—osteoporosis	0.000455	0.00115	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—PTHLH—osteoporosis	0.000453	0.00115	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SOST—osteoporosis	0.000452	0.00114	CbGpPWpGaD
Adenosine—Nausea—Estradiol—osteoporosis	0.000449	0.00076	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—POMC—osteoporosis	0.000446	0.00113	CbGpPWpGaD
Adenosine—ADA—Metabolism—IDH2—osteoporosis	0.000444	0.00112	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PTH—osteoporosis	0.000427	0.00108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MGLL—osteoporosis	0.000424	0.00107	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000417	0.00106	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP27A1—osteoporosis	0.000417	0.00105	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CNR2—osteoporosis	0.000417	0.00105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CALCR—osteoporosis	0.000409	0.00103	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTH1R—osteoporosis	0.000409	0.00103	CbGpPWpGaD
Adenosine—ADA—Metabolism—ACP5—osteoporosis	0.000406	0.00103	CbGpPWpGaD
Adenosine—ADK—Metabolism—ENO1—osteoporosis	0.000403	0.00102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ADCY5—osteoporosis	0.0004	0.00101	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PTH—osteoporosis	0.0004	0.00101	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CALCA—osteoporosis	0.000399	0.00101	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IRS1—osteoporosis	0.000398	0.00101	CbGpPWpGaD
Adenosine—ADK—Metabolism—PSMA2—osteoporosis	0.000397	0.001	CbGpPWpGaD
Adenosine—ADK—Metabolism—PSMA5—osteoporosis	0.000397	0.001	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—WNT1—osteoporosis	0.000392	0.00099	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.00039	0.000986	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CNR2—osteoporosis	0.00039	0.000986	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MGLL—osteoporosis	0.000382	0.000965	CbGpPWpGaD
Adenosine—ADA—Metabolism—TPI1—osteoporosis	0.000377	0.000954	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6R—osteoporosis	0.000374	0.000944	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LRP5—osteoporosis	0.000373	0.000942	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTH—osteoporosis	0.000363	0.000919	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—LEP—osteoporosis	0.000357	0.000902	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LRP6—osteoporosis	0.000356	0.000901	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000355	0.000897	CbGpPWpGaD
Adenosine—ADA—Metabolism—P4HB—osteoporosis	0.000355	0.000897	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PTHLH—osteoporosis	0.000354	0.000895	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CNR2—osteoporosis	0.000354	0.000895	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IRS2—osteoporosis	0.00035	0.000886	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SOST—osteoporosis	0.000349	0.000882	CbGpPWpGaD
Adenosine—ADA—Metabolism—GAPDH—osteoporosis	0.000348	0.00088	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CALCA—osteoporosis	0.000343	0.000868	CbGpPWpGaD
Adenosine—ADA—Metabolism—RAP1A—osteoporosis	0.000339	0.000857	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—WNT1—osteoporosis	0.000333	0.000842	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PTHLH—osteoporosis	0.000332	0.000838	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MGLL—osteoporosis	0.000325	0.000821	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP19A1—osteoporosis	0.000322	0.000815	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—POMC—osteoporosis	0.000318	0.000804	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LRP5—osteoporosis	0.000317	0.000801	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTH1R—osteoporosis	0.000316	0.000798	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CALCR—osteoporosis	0.000316	0.000798	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CALCA—osteoporosis	0.000312	0.000788	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PTH—osteoporosis	0.000309	0.000781	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—POMC—osteoporosis	0.000307	0.000775	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IRS1—osteoporosis	0.000306	0.000773	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LRP6—osteoporosis	0.000303	0.000766	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTHLH—osteoporosis	0.000301	0.000761	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CNR2—osteoporosis	0.000301	0.000761	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TLN1—osteoporosis	0.000301	0.000761	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—IL6—osteoporosis	0.000296	0.000747	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—IGF1—osteoporosis	0.000295	0.000745	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CALCA—osteoporosis	0.000292	0.000738	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6R—osteoporosis	0.000287	0.000726	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTH—osteoporosis	0.000281	0.000709	CbGpPWpGaD
Adenosine—ADA—Metabolism—ENO1—osteoporosis	0.000274	0.000693	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000274	0.000693	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CNR2—osteoporosis	0.000273	0.000691	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—POMC—osteoporosis	0.00027	0.000683	CbGpPWpGaD
Adenosine—ADA—Metabolism—PSMA2—osteoporosis	0.00027	0.000683	CbGpPWpGaD
Adenosine—ADA—Metabolism—PSMA5—osteoporosis	0.00027	0.000683	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CALCA—osteoporosis	0.000265	0.00067	CbGpPWpGaD
Adenosine—ADK—Metabolism—ADCY5—osteoporosis	0.000263	0.000666	CbGpPWpGaD
Adenosine—ADK—Metabolism—GPX1—osteoporosis	0.000263	0.000664	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—P4HB—osteoporosis	0.00026	0.000656	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—WNT1—osteoporosis	0.000257	0.00065	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PTHLH—osteoporosis	0.000256	0.000647	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TLN1—osteoporosis	0.000256	0.000647	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTH—osteoporosis	0.000252	0.000638	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MGLL—osteoporosis	0.000251	0.000634	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RAP1A—osteoporosis	0.000248	0.000627	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CNR2—osteoporosis	0.000246	0.000622	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LRP5—osteoporosis	0.000245	0.000619	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—ADCY5—osteoporosis	0.000244	0.000617	CbGpPWpGaD
Adenosine—ADK—Metabolism—MTHFR—osteoporosis	0.000242	0.000613	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFATC1—osteoporosis	0.000242	0.000612	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—DKK1—osteoporosis	0.00024	0.000607	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LRP6—osteoporosis	0.000234	0.000592	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTHLH—osteoporosis	0.000233	0.000588	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—WNT1—osteoporosis	0.000231	0.000585	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CALCA—osteoporosis	0.000225	0.00057	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGA—osteoporosis	0.000225	0.000569	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000222	0.000561	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—P4HB—osteoporosis	0.000221	0.000558	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—osteoporosis	0.00022	0.000556	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP19A1—osteoporosis	0.000219	0.000554	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTH—osteoporosis	0.000215	0.000543	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RAP1A—osteoporosis	0.000211	0.000533	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTHLH—osteoporosis	0.000209	0.000529	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CNR2—osteoporosis	0.000209	0.000529	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BMP2—osteoporosis	0.000209	0.000529	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—POMC—osteoporosis	0.000209	0.000528	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—ADCY5—osteoporosis	0.000208	0.000525	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFATC1—osteoporosis	0.000206	0.00052	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGB—osteoporosis	0.000205	0.000518	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CALCA—osteoporosis	0.000205	0.000517	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—DKK1—osteoporosis	0.000204	0.000516	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PSMA5—osteoporosis	0.000198	0.0005	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PSMA2—osteoporosis	0.000198	0.0005	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TLN1—osteoporosis	0.000198	0.0005	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—WNT1—osteoporosis	0.000197	0.000497	CbGpPWpGaD
Adenosine—ADK—Metabolism—POMC—osteoporosis	0.000194	0.00049	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGA—osteoporosis	0.000191	0.000484	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ADCY5—osteoporosis	0.000189	0.000477	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CALCA—osteoporosis	0.000184	0.000466	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—POMC—osteoporosis	0.00018	0.000454	CbGpPWpGaD
Adenosine—ADA—Metabolism—ADCY5—osteoporosis	0.000179	0.000453	CbGpPWpGaD
Adenosine—ADA—Metabolism—GPX1—osteoporosis	0.000178	0.000451	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTHLH—osteoporosis	0.000178	0.00045	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BMP2—osteoporosis	0.000178	0.00045	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGB—osteoporosis	0.000174	0.00044	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—P4HB—osteoporosis	0.00017	0.000431	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—osteoporosis	0.00017	0.000429	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSMA5—osteoporosis	0.000168	0.000425	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSMA2—osteoporosis	0.000168	0.000425	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KL—osteoporosis	0.000167	0.000423	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	0.000166	0.000421	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTH—osteoporosis	0.000166	0.000419	CbGpPWpGaD
Adenosine—ADA—Metabolism—MTHFR—osteoporosis	0.000165	0.000416	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—POMC—osteoporosis	0.000163	0.000412	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RAP1A—osteoporosis	0.000163	0.000412	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR2—osteoporosis	0.000162	0.000408	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.00016	0.000405	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6R—osteoporosis	0.000159	0.000402	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFATC1—osteoporosis	0.000159	0.000402	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DKK1—osteoporosis	0.000158	0.000399	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CALCA—osteoporosis	0.000157	0.000396	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—POMC—osteoporosis	0.000153	0.000386	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—WNT1—osteoporosis	0.000152	0.000384	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGA—osteoporosis	0.000148	0.000373	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADCY5—osteoporosis	0.000146	0.000368	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KL—osteoporosis	0.000142	0.00036	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—osteoporosis	0.000139	0.000351	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTHLH—osteoporosis	0.000137	0.000347	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BMP2—osteoporosis	0.000137	0.000347	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6R—osteoporosis	0.000135	0.000342	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGB—osteoporosis	0.000134	0.00034	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—osteoporosis	0.000132	0.000333	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADCY5—osteoporosis	0.000131	0.000331	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSMA2—osteoporosis	0.00013	0.000328	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSMA5—osteoporosis	0.00013	0.000328	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—osteoporosis	0.000128	0.000324	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SPP1—osteoporosis	0.000127	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CALCA—osteoporosis	0.000121	0.000306	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—osteoporosis	0.000118	0.000298	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS2—osteoporosis	0.000115	0.00029	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—osteoporosis	0.000112	0.000284	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADCY5—osteoporosis	0.000111	0.000282	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KL—osteoporosis	0.00011	0.000278	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SPP1—osteoporosis	0.000108	0.000272	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—osteoporosis	0.000107	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—osteoporosis	0.000107	0.000271	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6R—osteoporosis	0.000104	0.000264	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS1—osteoporosis	0.0001	0.000253	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS2—osteoporosis	9.75e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—osteoporosis	9.64e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—osteoporosis	9.54e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6R—osteoporosis	9.4e-05	0.000238	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—osteoporosis	9.27e-05	0.000234	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—osteoporosis	9.11e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADCY5—osteoporosis	8.6e-05	0.000217	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS1—osteoporosis	8.51e-05	0.000215	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SPP1—osteoporosis	8.32e-05	0.00021	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—osteoporosis	8.19e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6R—osteoporosis	7.99e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—osteoporosis	7.88e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS2—osteoporosis	7.53e-05	0.00019	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—osteoporosis	7.36e-05	0.000186	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—osteoporosis	7.09e-05	0.000179	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—osteoporosis	7.03e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS1—osteoporosis	6.57e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—osteoporosis	6.33e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6R—osteoporosis	6.17e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—osteoporosis	6.09e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—osteoporosis	6.03e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—osteoporosis	5.57e-05	0.000141	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—osteoporosis	5.56e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—osteoporosis	4.74e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—osteoporosis	4.73e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—osteoporosis	4.65e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—osteoporosis	4.19e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—osteoporosis	3.66e-05	9.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—osteoporosis	3.65e-05	9.22e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—osteoporosis	3.56e-05	9e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—osteoporosis	2.75e-05	6.95e-05	CbGpPWpGaD
